Management of early aggressive rheumatoid arthritis during pregnancy and lactation

Ostensen, Monika (2009). Management of early aggressive rheumatoid arthritis during pregnancy and lactation. Expert opinion on pharmacotherapy, 10(9), pp. 1469-79. London: Informa Healthcare 10.1517/14656560902980194

Full text not available from this repository. (Request a copy)

This survey outlines the problems of drug therapy in women with early aggressive rheumatoid arthritis (RA) who desire children, are pregnant, or are lactating. Solutions for treatment that benefit the mother and do not harm the fetus or the breast-fed child are discussed. The most effective immunosuppressive drugs alone or in combination are contraindicated during pregnancy and, to a lesser degree, also during lactation. Judicious timing of therapy is therefore necessary, aiming at fast remission of symptoms with the most effective therapy and maintaining quiescent disease with drugs compatible with pregnancy or lactation.

Item Type:

Journal Article (Further Contribution)

Division/Institute:

04 Faculty of Medicine > Department of Dermatology, Urology, Rheumatology, Nephrology, Osteoporosis (DURN) > Clinic of Rheumatology, Clinical Immunology and Allergology

UniBE Contributor:

Oestensen, Monika Elisabeth

ISSN:

1465-6566

Publisher:

Informa Healthcare

Language:

English

Submitter:

Factscience Import

Date Deposited:

04 Oct 2013 15:11

Last Modified:

04 May 2014 23:23

Publisher DOI:

10.1517/14656560902980194

PubMed ID:

19505214

Web of Science ID:

000267416400008

URI:

https://boris.unibe.ch/id/eprint/31437 (FactScience: 195953)

Actions (login required)

Edit item Edit item
Provide Feedback